News Opinion Editor's Corner ACC 2025 What’s Going to Be Hot at ACC 2025? Michael O'Riordan March 26, 2025
News Daily News ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain Todd Neale March 25, 2024
News Daily News Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability Todd Neale September 13, 2023
News Daily News Subclinical HFpEF Common in Patients Undergoing AF Ablation Todd Neale September 08, 2023
News Conference News ESC 2023 New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground Caitlin E. Cox August 30, 2023
News Daily News Generic Dabigatran Lots Pulled for Nitrosamine Impurity Michael O'Riordan March 28, 2023
News Daily News Many ESC Guideline Recommendations Out of Reach in Poorer Regions Michael O'Riordan November 29, 2022
News Conference News ESC 2022 CV Care Around Noncardiac Surgery: New ESC Guidelines Michael O'Riordan September 07, 2022
News Opinion Editor's Corner ESC 2022 What’s Going to Be Hot at ESC 2022? Shelley Wood August 22, 2022
News Conference News HRS 2022 Gains in HF Drug Therapy Raise Questions About ICD Benefit in Modern Era Todd Neale May 02, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2021 Caitlin E. Cox May 03, 2021
News Conference News EHRA 2021 RACE 3: Effects Wane for Targeted Therapy in Early AF, HF Todd Neale April 26, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2021 Shelley Wood February 03, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for June 2020 Shelley Wood July 02, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2020 Shelley Wood June 04, 2020
News Daily News US Prescriptions During COVID-19: Hydroxychloroquine Soars, CVD Drugs Stable Shelley Wood May 29, 2020
News Conference News ESC 2016 ICDs Do Not Reduce Mortality in Patients With HF Not Caused by Coronary Artery Disease: DANISH Michael O'Riordan August 28, 2016